PET imaging with sodium fluoride (NaF) changed treatment in more than half of men with prostate cancer and could prove to be a better tool than bone scintigraphy, according to an analysis from the National Oncologic PET Registry (NOPR) published online February 27 in the Journal of Nuclear Medicine.  {read more here}

A novel theranostic agent has the ability to target melanoma and provide radionuclide therapy in preliminary investigation, according to a study published March 13 in the Journal of Nuclear Medicine . {read more here}

After waiting patiently for sodium F-18 fluoride PET/CT data to come out of the National Oncological PET Registry (NOPR), clinicians are now clear that that the scan benefits patients by changing their course of care, at the very least, 12 percent of the time, according to a review published March 10 in the Journal of Nuclear Medicine. {read more here}

The financial impact of ICD-10 is expected to be manageable for nonprofit hospitals, but the potential for a revenue cycle disruption could have negative credit reverberations, according to a new Fitch Ratings report. {read more here}